Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Clinical trial NCT00119262 · COMPLETED

Trial details

NCT number: NCT00119262
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Male Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer

Start date: 2005-10-01
Primary completion: 2009-08-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.